|
1.
|
Sickles EA: Breast masses: mammographic
evaluation. Radiology. 173:297–303. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Donegan WL: Evaluation of a palpable
breast mass. N Engl J Med. 327:937–942. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Kopans DB: Rastreamento do câncer de mama.
Kopans DB and Bertud M: Imagem da Mama. 2nd edition. Medsi; Rio de
Janeiro: pp. 55–99. 2000
|
|
4.
|
Sickles EA: Mammographic features of 300
consecutive nonpalpable breast cancers. Am J Roentgenol.
146:661–663. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Khalkhali I, Mena I and Diggles L: Review
of imaging techniques for the diagnosis of breast cancer: a new
role of prone scintimammography using technetium-99m setamibi. Eur
J Nucl Med. 21:357–362. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Kalisher L: Factors influencing false
negative rates in xeromammography. Radiology. 133:297–301. 1979.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Rosenberg RD, Hunt WC, Williamson MR, et
al: Effects of age, breast density, ethnicity and estrogen
replacement therapy on screening mammographic sensitivity and
cancer stage at diagnosis: review of 183,134 screnning mammograms
in Albuquerque, New Mexico. Radiology. 209:511–518. 1998.
View Article : Google Scholar
|
|
8.
|
Mandelson MT, Oestreicher N, Porter PL, et
al: Breast density as a predictor of mammographic detection:
comparison of interval- and screen-detected cancers. J Natl Cancer
Inst. 92:1081–1087. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Mann BD, Giuliano AE, Basset LW, Barber
MS, Hallauer W and Morton DL: Delayed diagnosis of breast cancer as
a result of normal mammograms. Arch Surg. 118:23–24. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Vespoli HM, De Luca LA, Rodrigues JR and
Uemura G: Natureza histopatológica de microcalcificações presentes
em lesões não nodulares classificadas como Birads 4. Rev Bras
Mastol. (In press).
|
|
11.
|
Waxman AD, Ramanna L, Memsic LD, et al:
Thallium scintigraphy in the evaluation of mass abnormalities of
the breast. J Nucl Med. 34:18–23. 1993.PubMed/NCBI
|
|
12.
|
Lyra M and Vamvakas I: Dosimetry in
scintimammography by (99m)Tc-MuIotaBetaIota, (99m)Tc-tetrofosmin,
(99m)Tc-(V) DMSA and 201TlCl compared with X-rays mammography. Hell
J Nucl Med. 12:184–188. 2009.PubMed/NCBI
|
|
13.
|
Taillefer R: The role of 99mTc-sestamibi
and other conventional radiopharmaceuticals in breast cancer
diagnosis. Semin Nucl Med. 19:16–40. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Chiu ML, Kronauge JF and Piwnica-Worms D:
Effect of mitochondrial and plasma membrane potentials on
accumulation of hexakis (2-methoxyisobutylisonitrile) technetium
(I) in cultured mouse fibroblasts. J Nucl Med. 31:1646–1653.
1990.PubMed/NCBI
|
|
15.
|
Pwnica-Worms D, Kronauge JF and Ciu ML:
Uptake and retention of hexakis (2-methoxyisobutyl isonitrile)
technetium(I) in cultured chick myocardial cells. Mitochondrial and
plasma membrane potential dependence. Circulation. 82:1826–1838.
1990. View Article : Google Scholar
|
|
16.
|
Carvalho PA, Chiu ML, Kronauge JF, et al:
Subcellular distribuition and analysis of technetium-99m-MIBI in
isolated perfused rat hearts. J Nucl Med. 33:516–522.
1992.PubMed/NCBI
|
|
17.
|
Omar WS, Eissa S, Moustafa H, Farag H,
Ezzat I and Abdel-Dayem HM: Role of thallium 201 cloride and Tc99m
methoxy-isobutyl-isonitrile sestamibi in evaluation of breast
masses: correlation with immunohistochemical characteristic
parameters Ki-63 PCNA, BCI-2 and angiogenesis in malignant lesions.
Anticancer Res. 17:1639–1644. 1997.
|
|
18.
|
Cutrone JA, Yospur LS, Khalkhali I, et al:
Immunohistologic assessment of technetium-99m-MIBI uptake in benign
and malignant breast lesions. J Nucl Med. 39:449–453.
1998.PubMed/NCBI
|
|
19.
|
Tierney S, Fenlon HM, Phelan N, O'Sullivan
P, Ennis JT and Gorey TF: Scintimammography in the assessment of
local recurrence following conservative breast surgery. Br J Surg.
85:511998.
|
|
20.
|
Cutrone JA, Khalkhali I, Yospur LS, et al:
Tc-99m sestamibi scintimammography for the evaluation of breast
masses in patients with radiographically dense breasts. Breast.
5:383–388. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Zegel H, Heller L, Edell S, Squires F and
Rubin J: Tc-99m sestamibi scintimammography dense breast. Clin Nucl
Med. 24:968–975. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Kuhn JC, Siegel A, Poplack S and Arrick B:
Chest wall recurrence of breast cancer detected by
scintimammography. Clin Nucl Med. 25:104–107. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Kolasinska AD, Cwikla JB, Buscombe JR, et
al: Scintimammography in recurrent breast cancer: a primary or
secondary role? Nucl Med Commun. 21:389–390. 2000. View Article : Google Scholar
|
|
24.
|
Usmani S, Khan HA, Niaz K, et al:
Tc-99m-methoxy isobutyl isonitrile scintimammography: imaging
postexcision biopsy for residual and multifocal tumor. Nucl Med
Commun. 29:826–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Diggles L, Mena I and Khalkhali I:
Technical aspects of prone dependent-breast scintimammography. J
Nucl Med Technol. 22:165–170. 1994.
|
|
26.
|
Khalkhali I, Mena I and Jouanne E: Prone
scintimammography in patients with suspicion of breast cancer. J Am
Coll Surg. 78:491–497. 1994.
|
|
27.
|
Zajicek J: Aspiration biopsy cytology Part
I Cytology of supra diaphragmatic organs. Basel: S. Karger; 4. pp.
37pp. 38pp. 481974
|
|
28.
|
Faraj M, Antunes LC and Ribeiro RM:
Aspectos básicos da interpretação dos exames complementares. J Bras
Med. 62:124–129. 1992.
|
|
29.
|
Siegel S: Estatística não Paramétrica
(Para as Ciências do Comportamento). McGraw Hill. São Paulo:
1975.
|
|
30.
|
Fleiss JL: Statistical Methods for Rates
and Proportions. John Wiley. New York: 1973.
|
|
31.
|
Rosner B: Fundamental of Biostatistics
(2nd edition). Duxbury Press. Boston: 1986.
|
|
32.
|
Curi PR: Metodologia e Análise de Pesquisa
em Ciências Biológicas. 2nd edition. Tipomic; Botucatu: 1998
|
|
33.
|
Harris JR, Hellman S, Henderson IC and
Kinne DW: Breast Diseases. Lippincott. Philadelphia: 1987.
|
|
34.
|
Inanir S, Kiliç AK, Özdemir E and
Zorlutuna Y: Technetium-99m-methylene diphosphonate
scintimammography in male breast cancer. J Nucl Med. 39:28–29.
1998.PubMed/NCBI
|
|
35.
|
Liu M, Husain SS, Hameer HR and Gona JM:
Detection of male breast cancer with Tc-99m
methoxyisobutylisonitrile. Clin Nucl Med. 24:882–883. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Marwah A, Kumar R, Bharathi D, Sharma S,
Bandopadhyaya GP and Malhotra A: Tc-99m Tetrofosmin uptake in male
breast cancer. Clin Nucl Med. 26:77–78. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Kao CH, Wang SJ and Liu TJ: The use of
technetium-99m methoxyisobutylisonitrile breast scintigraphy to
evaluate palpable breast masses. Eur J Nucl Med. 215:432–436.
1994.PubMed/NCBI
|
|
38.
|
Khalkhali I, Cutrone JA, Mena IG, et al:
Scintimammography: the complementary role of Tc-99m sestamibi prone
breast imaging for the diagnosis of breast carcinoma. Radiology.
196:421–426. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Palmedo H, Biersack HJ, Lastoria S, et al:
Scintimammography with technetium-99m methoxyisobutylisonitrile:
results of a prospective European multicentric trial. Eur J Nucl
Med. 25:375–385. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Khalkhali I, Villanueva-Meyer J, Edell SL,
et al: Diagnostic accuracy of 99mTc-sestamibi breast
imaging: multicenter trial results. J Nucl Med. 41:1973–1979.
2000.
|
|
41.
|
Alonso O, Massardo T, Delgado LB, et al:
Is 99mTc-sestamibi scintimammography complementary to conventional
mammography for detecting breast cancer in patients with palpable
masses? J Nucl Med. 42:1614–1621. 2001.
|
|
42.
|
Massardo T, Alonso O, Kabasakal L, et al:
Diagnostic value of 99mTc-methylene diphosphonate and
99mTc-pentavalent DMSA compared with 99mTc-sestamibi for palpable
breast lesions. J Nucl Med. 43:882–888. 2002.PubMed/NCBI
|
|
43.
|
Taillefer R, Robidoux A, Lambert R, Turpin
S and Laperriere J: Technetium-99m-sestamibi prone
scintimammography to detect primary breast cancer and axillary
lymph node involvement. J Nucl Med. 36:1758–1765. 1995.PubMed/NCBI
|
|
44.
|
Khalkhali I, Cutrone J, Mena I, et al:
Technetium-99m-sestamibi scintimammography of breast lesions:
clinical and pathological follow-up. J Nucl Med. 36:1784–1789.
1995.PubMed/NCBI
|
|
45.
|
Palmedo H, Bender H, Grünwald F, et al:
Comparison of fluorine-18 fluorodeoxiglucose positron emission
tomography and technetium-99m methoxyisobutylisonitrile
scintimammography in the detection of brest tumours. Eur J Nucl
Med. 24:1138–1145. 1997.
|
|
46.
|
Buscombe JR, Cwikla JB, Holloway B and
Hilson AJW: Prediction of the usefulness of combined mammography
and scintimammography in suspected primary breast cancer using ROC
curves. J Nucl Med. 42:3–8. 2001.PubMed/NCBI
|
|
47.
|
Rice SJ, Khalkhali I and Diggles L: The
role of radionuclide breast imaging in the evaluation of suspected
breast abnormalities. Breast Dis. 10:177–187. 1998.PubMed/NCBI
|
|
48.
|
Cwikla JB, Buscombe JR, Kelleher SM, et
al: Comparison of accuracy of scintimammography in the diagnosis of
primary breast cancer in patients selected for surgical biopsy.
Clin Radiol. 53:274–280. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Khalkhali I and Vargas H: The role of
nuclear medicine in breast cancer detection: functional breast
imagery. Radiol Clin of North Am. 39:1053–1068. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Koukouraki S, Koukourakis MI, Vagios E,
Velidaki A, Tsiftsis D and Karkavitsas N: The role of
99mTc-sestamibi scintimammography and colour Doppler
ultrasonography in the evaluation of breast lesions. Nucl Med
Commun. 22:1243–1248. 2001.
|
|
51.
|
Nuclear imaging test cleared by the FDA.
Women's Health Weekly, 06/09/97-06/16/97, p3,2p.
|
|
52.
|
Waxman A: The role of 99mTc
methoxyisobutylisonitrile in imaging breast cancer. Semin Nucl Med.
27:40–54. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
53.
|
Liberman M, Sampalis F, Mulder DS and
Sampalis JS: Breast cancer diagnosis by scintimammography: a
meta-analysis and review of the literature. Breast Cancer Res
Treat. 80:115–126. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
54.
|
Hussain R and Buscombe JR: A meta-analysis
of scintimammography: an evidence based approach to its clinical
utility. Nucl Med Commun. 27:589–559. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
55.
|
Barros AC, Marques JA, Souza AZ, et al:
Cintilografia mamária com tecnécio-99m-sestamibi: fundamentos do
método e experiência clínica inicial. Rev Ginecol Obstet.
6:119–123. 1995.
|
|
56.
|
Lima MCL, Cunha DC, Etchebehere ECSC, et
al: Mamocintilografia com sestamibi-99mTc no diagnóstico
de lesões de mama. Rev Bras Mastol. 1:3–9. 2000.
|
|
57.
|
Buscombe JR, Cwikla JB, Thakrar DS and
Hilson A: Uptake of Tc-99m MIBI related to tumor size and type.
Anticancer Res. 17:1693–1694. 1997.PubMed/NCBI
|
|
58.
|
Nachar O, Rousseau J, Ouellet R, et al:
Scintimammogaphy with
11β-methoxy-(17α,2OZ)-[123I]Iodovinylestradiol: a
complementary role to 99mTc-metoxyisobutylisonitrile in
the characterization of breast tumors. J Nucl Med. 41:1324–1331.
2000.
|
|
59.
|
Tavassoli FA: Pathology of the Breast.
Elsevieir; New York: 1992
|
|
60.
|
Owen HW, Dockerty MB and Gray HK: Occult
carcinoma of the breast. Surg Gynecol Obstet. 98:3021954.PubMed/NCBI
|
|
61.
|
Fitts WT, Steiner GC and Enterline HT:
Prognosis of occult carcinoma of the breast. Am J Surg.
106:4601963. View Article : Google Scholar
|
|
62.
|
Haagensen CD: The diagnosis of breast
carcinoma. Diseases of the Breast. Saunders WB; Philadelphia: pp.
4861971
|
|
63.
|
Baron PL, More MP and Kinne DW: Occult
breast cancer presenting with axillary metastases: updated
management. Arch Surg. 125:2101990. View Article : Google Scholar : PubMed/NCBI
|
|
64.
|
Scoggins CR, Vitola JV, Sandler MP,
Atkinson JB and Frexes-Steed M: Occult breast carcinoma presenting
as an axillary mass. Am Surg. 65:1–5. 1999.PubMed/NCBI
|
|
65.
|
Prats E, Aisa F, Abós MD, et al:
Mammography and 99mTc-MIBI scintimammography in suspected breast
cancer. J Nucl Med. 40:296–301. 1999.PubMed/NCBI
|
|
66.
|
Uriarte I, Carril JM, Quirce R, et al:
Optimization of X-ray mammography and technetium-99m
methoxyisobutylisonitrile scintimammogrpahy in the diagnosis of
non-palpable breast lesions. Eur J Nucl Med. 25:491–496. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
67.
|
Black MM, Barclay THC and Culter SJ:
Association of atypical characteristics of benign breast lesions
with subsequent risk of breast cancer. Cancer. 29:338–343. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
68.
|
Dupont WD and Page DL: Risk factors for
breast cancer in women with proliferative breast cancer in women
with proliferative breast disease. N Eng J Med. 312:146–151. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
69.
|
Tobias P, De Luca LA, Schmitt FCL,
Frederigue U Jr and Uemura G: A histological review and critical
analysis of fibroadenomas. Rev Bras Mastol. 9:68–74. 1999.
|
